Home›People›Douglas Boothe
DB

Douglas Boothe

Director at Ionetix Corp / DE /. Also a director at Ionetix.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Apr 21, 2026·Suggest an edit

About Douglas Boothe

Douglas Boothe is a director at Ionetix Corp / DE /.

Form D filings name Douglas Boothe as a director at Ionetix.

Douglas Boothe reports to the SEC as a director or officer of 5 public companies, including Akorn (AKRXQ), Impax Laboratories (IPXL) and Perrigo Co. PLC (PRGO).

Douglas Boothe first appears on SEC filings in 2013.

Experience

This experience comes from SEC filings. The years are when the filings name Douglas Boothe in the role, so the role may have started earlier or lasted longer.

Ionetix Corp / DE /
Director
2026 · Public company
Ionetix Corp
Director
2024 · Lansing, MI
Akorn Inc.
President and CEO, director
2019 – 2020 · Public company (AKRXQ)
Impax Laboratories, LLC
President, Generics Division
2016 – 2018 · Public company (IPXL)
Perrigo Co. PLC
EVP & GM Perrigo Pharma
2013 – 2016 · Public company (PRGO)
Perrigo Co.
EVP & GM Perrigo Pharma
2013 · Public company (PRGO)

Key Colleagues at Startups

The people Douglas Boothe works with at each company, as listed on that company's latest Form D.

Ionetix Corp · Form D, Aug 26, 2024
DM
David Martin
Director
AS
Anthony Stagnolia
Executive officer
DE
David Eve
Executive officer
GT
PP
Phun Phieu
Executive officer
MT
GM
KC
Kevin Cameron
Executive officer and director

Sources

  1. SECIonetix Corp Form D, filed Aug 26, 2024
  2. SECForms 3, 4 and 5 filed by Douglas Boothe (SEC filer 1566118)